Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-25 @ 3:53 AM
NCT ID:
NCT07256002
Eligibility Criteria:
Inclusion Criteria:
1. Patients who visited the hospital from January 2020 to December 2023;
2. Received neoadjuvant immunotherapy before surgery;
3. Histologically diagnosed with stage II-III NSCLC;
4. Had measurable lesions as assessed by the investigator using the RECIST 1.1 version;
5. Underwent radical surgical treatment;
6. ECOG score of 0 or 1;
7. Available tumor tissue samples;
8. Good blood and organ functions.
Exclusion Criteria:
1. Has received other anti-tumor treatments before, including radiotherapy, chemotherapy and traditional Chinese medicine-based cancer treatment (except for malignant tumor treatments that have been cured and have no recurrence or metastasis for more than 5 years);
2. Has a history of previous malignant tumors.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT07256002
Study Brief:
Protocol Section:
NCT07256002